A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors
Condition(s)
Solid Tumor
Molecular Target(s)
CDKN2A, MTAP
Drug Classification(s)
Immunotherapy, Molecular Targeted Therapy
Agents(s)
MCLA-129-CL01
Phase(s)
I/II
Mechanism of Action
n/a
Purpose
n/a
Location
Mary Crowley Cancer Research - Medical City Dallas
Connect With Us
Whether you want to give a spark of hope or you are looking for it, we are here to help. If you have any questions or concerns, please contact us here.
7777 Forest Lane,
Building C-707
Dallas, TX 75230
972.566.3000